A23V 2250/161
Magnesium
A23V2250/161 (Magnesium) appears on 28 US grants and 55 published applications in this corpus.
Search patents in A23V- Granted patents
- 28
- Published applications
- 55
- Assignees
- 27
- Inventors
- 75
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 1 | 7 |
| 2019 | 0 | 16 |
| 2020 | 6 | 6 |
| 2021 | 4 | 3 |
| 2022 | 7 | 6 |
| 2023 | 2 | 4 |
| 2024 | 3 | 3 |
| 2025 | 1 | 5 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nutritional compositions and infant formula for promoting de novo myealination21 Jul 2026US 12,685,331 B2Societe des Produits Nestle S. A.
- Composition for producing hydrogen rich water and other products31 Mar 2026US 12,588,693 B2H2 Water Technologies Ltd.
- Nutritional composition and infant formula for promoting de novo myelination2 Dec 2025US 12,484,608 B2Societe des Produits Nestle S. A.
- Nutritional supplements22 Oct 2024US 12,121,050 B2Laminaria Group AB
- Nutritional composition and infant formula for promoting de novo myelination21 May 2024US 11,986,003 B2Societe des Produits Nestle S. A.
- Particulate Composition, Gel Composition and Food Product11 Dec 2025US 2025/0374947 A1House Foods Corporation
- Compositions and their use11 Sep 2025US 2025/0280863 A1Societe des Produits Nestle S. A.
- Deuterated caffeine and uses thereof7 Aug 2025US 2025/0248424 A1Lennham Pharmaceuticals, Inc.
- Nutritional supplements1 May 2025US 2025/0134150 A1Laminaria Group AB
- Compositions and methods using a combination of oleuropein and magnesium9 Jan 2025US 2025/0009774 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Composition for countering the effects of alcohol consumption5US 8,507,015 B2Lquid Innovations, LLC · 2013
- Deuterated caffeine and uses thereof4US 10,582,716 B1Lennham Pharmaceuticals, Inc. · 2020
- Deuterated caffeine and uses thereof3US 10,765,130 B1Lennham Pharmaceuticals, Inc. · 2020
- Nutritional formulations using human milk oligosaccharides for modulating inflammation2US 10,624,916 B2Abbott Laboratories · 2020
- Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers2US 11,154,496 B2NordicCan A/S · 2021